Companies / Atara Biotherapeutics
Atara Biotherapeutics
United States
Atara Biotherapeutics is an allogeneic T-cell immunotherapy company that develops transformative therapies for patients with cancer and autoimmune conditions.
Atara Biotherapeutics, based in United States, has 2 investors on file, among them DAG Ventures and Kleiner Perkins. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from DAG Ventures
56 companies on its checked portfolioIts portfolio leans to Fintech (20%), Healthcare & Biotech (11%), Enterprise Software (11%).
More from Kleiner Perkins
310 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (26%), Healthcare & Biotech (13%), Enterprise Software (11%).
See Kleiner Perkins' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Atara Biotherapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when DAG Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/atarabio.com/investors
# also
GET /v1/companies/atarabio.com
GET /v1/companies/atarabio.com/news